These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Incobotulinum Toxin-A in Professional Musicians with Focal Task-Specific Dystonia: A Double Blind, Placebo Controlled, Cross-Over Study. Frucht SJ; George MC; Pantelyat A; Altenmueller E; Nmashie A; Jiao JM; Chen M; Feng D; Shin S; Kaku MC; Simpson D Tremor Other Hyperkinet Mov (N Y); 2024; 14():32. PubMed ID: 38948014 [TBL] [Abstract][Full Text] [Related]
4. Treatment of focal dystonia involving multiple muscles with a single injection of botulinum toxin A to 1 muscle: A case report. Lee SY; Lee HD; Cho YS; Han SH Medicine (Baltimore); 2018 Oct; 97(42):e12785. PubMed ID: 30334967 [TBL] [Abstract][Full Text] [Related]
5. Effect of botulinum toxin injection on length and force of the rectus femoris and triceps surae muscles during locomotion in patients with chronic hemiparesis (FOLOTOX). Supiot A; Geiger M; Bensmail D; Aegerter P; Pradon D; Roche N BMC Neurol; 2018 Aug; 18(1):104. PubMed ID: 30068305 [TBL] [Abstract][Full Text] [Related]
6. The effect of botulinum toxin injections to the calf muscles on freezing of gait in parkinsonism: a pilot study. Giladi N; Gurevich T; Shabtai H; Paleacu D; Simon ES J Neurol; 2001 Jul; 248(7):572-6. PubMed ID: 11517998 [TBL] [Abstract][Full Text] [Related]
7. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial. Zhang H; Lian Y; Ma Y; Chen Y; He C; Xie N; Wu C J Headache Pain; 2014 Sep; 15(1):65. PubMed ID: 25263254 [TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial. Attal N; de Andrade DC; Adam F; Ranoux D; Teixeira MJ; Galhardoni R; Raicher I; Üçeyler N; Sommer C; Bouhassira D Lancet Neurol; 2016 May; 15(6):555-65. PubMed ID: 26947719 [TBL] [Abstract][Full Text] [Related]
9. Botulinum Toxin type A injections for patients with painful hallux valgus: a double-blind, randomized controlled study. Wu KP; Chen CK; Lin SC; Pei YC; Lin RH; Tsai WC; Fuk-Tan Tang S Clin Neurol Neurosurg; 2015 Feb; 129 Suppl 1():S58-62. PubMed ID: 25683315 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of therapeutic benefits of botulinum toxin for foot dystonia associated with Parkinson's disease. Ni P; Xu YY; Wang LN; Cao JQ; Luo WF; Zhang QL; Li X; Zhou XP; Liu J Toxicon; 2024 Feb; 238():107587. PubMed ID: 38142904 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism. Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467 [TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A for neuropathic pain in patients with spinal cord injury. Han ZA; Song DH; Oh HM; Chung ME Ann Neurol; 2016 Apr; 79(4):569-78. PubMed ID: 26814620 [TBL] [Abstract][Full Text] [Related]
13. Drooling in Parkinson's disease: A randomized controlled trial of incobotulinum toxin A and meta-analysis of Botulinum toxins. Narayanaswami P; Geisbush T; Tarulli A; Raynor E; Gautam S; Tarsy D; Gronseth G Parkinsonism Relat Disord; 2016 Sep; 30():73-7. PubMed ID: 27406786 [TBL] [Abstract][Full Text] [Related]
14. An early botulinum toxin A treatment in subacute stroke patients may prevent a disabling finger flexor stiffness six months later: a randomized controlled trial. Hesse S; Mach H; Fröhlich S; Behrend S; Werner C; Melzer I Clin Rehabil; 2012 Mar; 26(3):237-45. PubMed ID: 21971750 [TBL] [Abstract][Full Text] [Related]
15. Assessment of Botulinum Neurotoxin Injection for Dystonic Hand Tremor: A Randomized Clinical Trial. Rajan R; Srivastava AK; Anandapadmanabhan R; Saini A; Upadhyay A; Gupta A; Vishnu VY; Pandit AK; Vibha D; Singh MB; Bhatia R; Goyal V; Dwivedi SN; Srivastava P; Prasad K JAMA Neurol; 2021 Mar; 78(3):302-311. PubMed ID: 33346814 [TBL] [Abstract][Full Text] [Related]
16. Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals. Sloop RR; Cole D; Patel MC Mov Disord; 2001 Jan; 16(1):100-5. PubMed ID: 11215566 [TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type B for gait freezing in Parkinson's disease. Fernandez HH; Lannon MC; Trieschmann ME; Friedman JH Med Sci Monit; 2004 Jul; 10(7):CR282-4. PubMed ID: 15232500 [TBL] [Abstract][Full Text] [Related]
18. A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia. Naumann M; Yakovleff A; Durif F; J Neurol; 2002 Jan; 249(1):57-63. PubMed ID: 11954869 [TBL] [Abstract][Full Text] [Related]
19. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis]. Wissel J; Entner T Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048 [TBL] [Abstract][Full Text] [Related]
20. Low-dose botulinum toxin-a treatment of cervical dystonia - a double-blind, randomized pilot study. Laubis-Herrmann U; Fries K; Topka H Eur Neurol; 2002; 47(4):214-21. PubMed ID: 12037435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]